Equitec Proprietary Markets’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Equitec Proprietary Markets’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$426K	Buy	+11,300	New	+$48K	0.13%	55

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Equitec Proprietary Markets's FPRX Position: Q1 2020 in Review

Equitec Proprietary Markets opened a new position in Five Prime Therapeutics, Inc. (FPRX) in Q1 2020: 11,300 shares worth $426K. The stake represents 0.13% of the portfolio and ranks #55 among its holdings.

87 funds tracked by Wall St. Rank hold FPRX as of Q1 2020.

Equitec Proprietary Markets held 11,300 shares of Five Prime Therapeutics, Inc. worth $426K as of Q1 2020.
Five Prime Therapeutics, Inc. was a new Equitec Proprietary Markets position in Q1 2020.
Five Prime Therapeutics, Inc. made up 0.13% of Equitec Proprietary Markets's portfolio in Q1 2020, its #55 holding.
87 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2020.

Based on Equitec Proprietary Markets's 13F filing for Q1 2020, filed 19 Apr 2021.